- Retraction Note
- Open Access
Retraction Note: Tripartite motif-containing 14 (TRIM14) promotes epithelial-mesenchymal transition via ZEB2 in glioblastoma cells
Journal of Experimental & Clinical Cancer Research volume 42, Article number: 74 (2023)
Retraction Note : J Exp Clin Cancer Res 38, 57 (2019)
The Editor-in-Chief has retracted this article. Concerns were raised regarding Figure 4B: the LN229 and U251 ZEB2 bands appear to be identical but flipped horizontally. Additionally, the authors have been unable to provide convincing documentation that ethics approval was obtained for this study. The Editor-in-Chief therefore no longer have confidence in the results and conclusions of this article.
Author Shuang Feng disagrees with this retraction. The other authors have not responded to correspondence regarding this retraction.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Feng, S., Cai, X., Li, Y. et al. Retraction Note: Tripartite motif-containing 14 (TRIM14) promotes epithelial-mesenchymal transition via ZEB2 in glioblastoma cells. J Exp Clin Cancer Res 42, 74 (2023). https://doi.org/10.1186/s13046-023-02646-9